Androgen-Deprivation Therapy Is More Than Palliation in Oligometastatic Prostate Cancer

J Clin Oncol. 2018 Aug 1;36(22):2350. doi: 10.1200/JCO.2018.78.0031. Epub 2018 Jun 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Androgen Antagonists
  • Humans
  • Male
  • Neoplasm Recurrence, Local
  • Prospective Studies
  • Prostatic Neoplasms*

Substances

  • Androgen Antagonists